Results 11 to 20 of about 487,389 (311)

Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease [PDF]

Zhongguo quanke yixue, 2022
China has attached importance to the prevention and treatment of chronic obstructive pulmonary disease (COPD) , a major chronic respiratory disease. An in-depth discussion of the immunopathogenesis of COPD and intervening the identified key targets may ...
Writing Group for the Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease
doaj   +1 more source

Chronic obstructive pulmonary disease

, 2010
This topic describes Chronic Obstructive Pulmonary Disease (COPD) in detail with different examples including chronic bronchitis and emphysema. The role of smoking is also discussed in relation to the disease.
Raja Habib, St George's, University of London   +1 more
core   +2 more sources

Expert Consensus on Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease (2023 Edition) [PDF]

Zhongguo quanke yixue, 2023
Chronic obstructive pulmonary disease (COPD) is one of the major chronic disease seriously affecting the health of Chinese residents. There are national and international guidelines and consensus on the diagnosis, treatment and management of COPD ...
Expert Consensus Writing Group of Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease
doaj   +1 more source

Clinical impact of long-term change in air trapping on pulmonary function and computed tomography parameters in chronic obstructive pulmonary disease [PDF]

The Korean Journal of Internal Medicine, 2021
Background/Aims Air trapping is associated with unfavorable outcomes in chronic obstructive pulmonary disease (COPD). The present study evaluated the association between longitudinal changes in air trapping with pulmonary function, computed tomography ...
Jeong Uk Lim, Jae Seung Lee, Ji-Hyun Lee, Sang-Do Lee, Yeon-Mok Oh, Chin Kook Rhee, for the Korean Obstructive Lung Disease (KOLD) Study Group   +6 more
doaj   +1 more source

Impact of moderate altitude on lung diseases and risk of high altitude illnesses

Revista de Investigación Clínica, 2022
A large world population resides at moderate altitudes. In the Valley of Mexico (2240 m above sea level) and for patients with respiratory diseases implies more hypoxemia and clinical deterioration, unless supplementary oxygen is prescribed or patients ...
Rogelio Pérez-Padilla
doaj   +1 more source

Neutrophilic Asthma Is Associated With Smoking, High Numbers of IRF5+, and Low Numbers of IL10+ Macrophages

Frontiers in Allergy, 2021
Asthma is a heterogenous disease with different inflammatory subgroups that differ in disease severity. This disease variation is hampering treatment and development of new treatment strategies.
Nil Turan, T. Anienke van der Veen, T. Anienke van der Veen, Christina Draijer, Christina Draijer, Fatemeh Fattahi, Fatemeh Fattahi, Fatemeh Fattahi, Nick H. ten Hacken, Nick H. ten Hacken, Wim Timens, Wim Timens, Antoon J. van Oosterhout, Maarten van den Berge, Maarten van den Berge, Barbro N. Melgert, Barbro N. Melgert, Barbro N. Melgert   +17 more
doaj   +1 more source

High-fiber diets attenuate emphysema development via modulation of gut microbiota and metabolism

Scientific Reports, 2021
Dietary fiber functions as a prebiotic to determine the gut microbe composition. The gut microbiota influences the metabolic functions and immune responses in human health.
Yoon Ok Jang, Ock-Hwa Kim, Su Jung Kim, Se Hee Lee, Sunmi Yun, Se Eun Lim, Hyun Ju Yoo, Yong Shin, Sei Won Lee   +8 more
doaj   +1 more source

The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review

The Lancet Global Health, 2022
Summary: Background: Asthma and chronic obstructive pulmonary disease (COPD) cause a considerable burden of morbidity and mortality in low-income and middle-income countries (LMICs).
Marie Stolbrink, BMBCh, Helen Thomson, MBChB, Ruth M Hadfield, PhD, Obianuju B Ozoh, PhD, Rebecca Nantanda, PhD, Shamanthi Jayasooriya, PhD, Brian Allwood, PhD, David M G Halpin, ProfDPhil, Sundeep Salvi, PhD, Maria Montes de Oca, ProfPhD, Kevin Mortimer, ProfPhD, Sarah Rylance, PhD   +11 more
doaj   +1 more source

Chronic obstructive pulmonary disease [PDF]

The Lancet, 1998
Acute exacerbations of underlying COPD are a common cause of respiratory deterioration. Developments have been made in preventive measures, but admission to hospital for acute exacerbations can be expected to remain common. Several expert consensus guidelines have been published to define the appropriate management of COPD patients.
Madison, J Mark, Irwin, Richard S
openaire   +2 more sources

Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. [PDF]

, 2011
: Chronic obstructive pulmonary disease (COPD) is a leading cause of disability in all its stages, and death in patients with moderate or severe obstruction.
van der Molen, T, Jones PW, Jones, P., van der Molen, T., Price, D, Price, David, Jones, PW, van der Molen, Thys, Jones, Paul W., Price D, van der Molen T, Price, D.   +11 more
core   +1 more source